tirzepatide uric acid reduction study on ingestive behavior in adults with overweight or obesity: a randomized 6-week phase 1 trial Tirzepatide Injections for Medical Weight
Description
Im on week 3 absolutely no problems
There is a small dose-dependent increase in HbA 1c reduction with the higher doses
Then use a fresh insulin syringe (29-31 gauge) for each dose
A two-month gap essentially means starting over
00070-5/asset/741f55c5-19b9-466e-8fd6-b3c5fb427911/main.assets/gr2_lrg.jpg)
This may blunt long-term sustainability of weight loss, as discontinuation of the drug has been associated with weight regain unless lifestyle strategies are continued [19]
